Credit Suisse Ag Mirum Pharmaceuticals, Inc. Call Options Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.4MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$257 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$173 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$130 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$111 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$109 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.45B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...